RNHD | Gu: Catching transcription factors for proteasomal degradation
Xin Gu, PhD, Assistant Professor, Department of Cancer Biology, Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School
to
RNHD | Chan: Exploiting dysregulated ribosome homeostasis for cancer therapy
Edmond M. Chan, MD, Assistant Professor of Medicine at Columbia University Irving Medical Center
to
RNHD | Nuñez: Rewriting the human epigenome with CRISPR
James Nuñez, PhD, Assistant Professor, Department of Molecular and Cell Biology at the University of California, Berkeley
to
RNHD | Welm: Modeling metastatic breast cancer to advance therapeutic strategies
Alana Welm, PhD, Ralph E. and Willia T. Main Presidential Endowed Chair in Cancer Research and Senior Director of Basic Science at the Huntsman Comprehensive Cancer Center, Professor of Oncological Sciences at the University of Utah, and Investigator at the Huntsman Cancer Institute
to
RNHD | Zervantonakis: Tumor-macrophage interactions in 3D microenvironments
Ioannis Zervantonakis, PhD, Assistant Professor of Bioengineering and William Kepler Whiteford Faculty Fellow at the University of Pittsburgh
to
RNHD | Newton: Protein Kinase C Unbalanced: Dysregulated Signaling in Cancer vs Alzheimer’s Disease
Alexandra Newton, PhD, Distinguished Professor of Pharmacology at UC San Diego
to
RNHD | Gomes: Understanding Cancer Through the Lens of Aging
Ana Gomes, PhD, Associate Member, Department of Molecular Oncology at Moffitt Cancer Center
to
RNHD | Stanger: Immune-based therapy for pancreas cancer: How do we thread the needle?
Ben Stanger, MD, PhD, Hanna Wise Professor in Cancer Research, Departments of Medicine and Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania
to
RNHD | Vander Heiden: How understanding metabolism has informed cancer biology
Matthew Vander Heiden, MD, PhD
to
